Pfizer plots €1.2B investment and up to 500 new jobs at Irish manufacturing plant
Dublin: Pfizer, a multinational pharmaceutical company, is preparing to invest heavily in Ireland. A 1.2 billion euro investment is being made in the manufacturing plant in Grange Castle, Dublin. The company’s announcement that it will employ 500 people. This was confirmed by Pfizer via email. This is the company’s largest investment in Ireland to date.
The upgrade will increase production and laboratory capacity at Emerald Ice to 5,500, the company said in a press release. The project, according to the company, will involve the construction of a new facility on the Grange Castle campus, which will double the site’s biopharmaceutical manufacturing capacity.
The current plan is to start construction in 2024 and complete it within the next five years. The company has additional locations in Kildare and Cork. The company, which has been in operation since 1969, has more than $8 billion in investments.
Grange Castle manufactures best-selling products such as the pneumococcal vaccine Preventer. The company provides drugs for arthritis, inflammation, cancer, infections, haemophilia, pain, and stroke. Last year, the company spent 40 million euros on the production of the Covid vaccine.
Irish Samachar English News
Kindly click the link below to join WhatsApp group chat to get important news and breaking news from Irish Samachar.
Comments are closed.